Artemis Medicare Services Limited Stock
Stocks
ARTEMISMED
INE025R01021
Healthcare Facilities & Services
|
Market Closed -
NSE India S.E.
07:05:06 2026-10-19 EDT
|
5-day change | 1st Jan Change | ||
| 301.25 INR | -1.66% |
|
-3.28% | +11.14% |
| Market Cap | 47.69B 503M 448M 415M 378M 709M 720M 4.98B 1.96B 24.93B 1.89B 1.85B 79.68B | P/E 2027 * |
36.4x | P/E 2028 * | 25.3x |
|---|---|---|---|---|---|
| Enterprise Value | 47.69B 503M 448M 415M 378M 709M 720M 4.98B 1.96B 24.93B 1.89B 1.85B 79.68B | EV / Sales 2027 * |
3.5x | EV / Sales 2028 * | 2.74x |
| Free-Float |
19.06% | Yield 2027 * |
0.15% | Yield 2028 * | 0.15% |
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| ARTEMISMED | Delayed | |
Bombay S.E.
| ARTEMISMED | Delayed |
| 1 day | -1.66% | ||
| 1 week | -3.28% | ||
| Current month | -12.82% | ||
| 1 month | -11.00% | ||
| 3 months | +11.84% | ||
| 6 months | +28.54% | ||
| Current year | +11.14% |
| 1 week | 300 |  | 313.1 |
| 1 month | 300 | | 378.8 |
| Current year | 203.35 | | 378.8 |
| 1 year | 203.35 | | 378.8 |
| 3 years | 136.1 | | 378.8 |
| 5 years | 32.25 | | 378.8 |
| 10 years | 10.67 | | 378.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | - | |
| Chief Tech/Sci/R&D Officer | - | 2025-05-11 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 2008-01-16 | |
| Chairman | 84 | 2006-09-13 | |
| Director/Board Member | - | 2006-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.66% | -3.28% | +23.46% | +85.38% | 511M | |
| +0.35% | +5.63% | +12.31% | +31.26% | 118B | |
| -0.86% | -0.81% | +6.74% | +86.39% | 99.34B | |
| +1.52% | +0.41% | +119.84% | +864.08% | 56.71B | |
| +2.78% | +4.83% | -5.38% | +81.02% | 28.56B | |
| -0.04% | +0.98% | +23.96% | +91.25% | 25.94B | |
| +0.28% | +1.05% | +11.50% | +59.87% | 25.79B | |
| -0.32% | -0.88% | +33.20% | +372.07% | 21.52B | |
| -1.26% | -2.79% | -21.43% | -4.70% | 20.7B | |
| +1.83% | -5.25% | +6.28% | +87.66% | 18.25B | |
| Average | +0.36% | -0.26% | +21.05% | +175.43% | 41.54B | |
| Weighted average by Cap. | +0.57% | +1.14% | +24.27% | +185.48% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 13.61B 144M 128M 119M 108M 202M 206M 1.42B 559M 7.11B 539M 527M 22.74B | 17.39B 183M 163M 151M 138M 258M 263M 1.82B 714M 9.09B 688M 674M 29.05B |
| Net income | 1.3B 13.68M 12.19M 11.29M 10.27M 19.27M 19.59M 135M 53.27M 678M 51.32M 50.24M 2.17B | 1.87B 19.72M 17.58M 16.29M 14.81M 27.79M 28.24M 195M 76.82M 977M 74M 72.45M 3.12B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-19 | ₹301.25 | -1.66% | 105,462 |
| 26-10-16 | ₹306.35 | +1.11% | 143,866 |
| 26-10-15 | ₹303.00 | +0.41% | 131,655 |
| 26-10-14 | ₹301.75 | -3.08% | 231,718 |
| 26-10-13 | ₹311.35 | -0.03% | 123,576 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ARTEMISMED Stock
Select your edition
All financial news and data tailored to specific country editions
